 Commercial Real Estate News (CRE) Medical Device Makers Terminate $945M Merger Plan, Citing US Judge's Adverse Ruling in FTC Case
2026-01-30 01:12 UTC by Globe StreetSulaiman Abdur-Rahmanhttps://feeds.feedblitz.com/-/943451420/0/globest/washington-dc.jpgAntitrust/Corporate Entities/Deals and Transactions/General Counsel and In House Counsel/Government/Litigation/Mergers and Acquisitions/Healthcare/Cases and Courts/Federal Government/Analysis"Ultimately, the Court cannot discount the high likelihood—as demonstrated by the FTC—that the Proposed Transaction, if consummated, will lead to significant anticompetitive effects," U.S. District Judge Rudolph Contreras wrote in a decision that prompted defendants Edwards Lifesciences Corp. and JenaValve Technology Inc. to terminate their proposed $945 million merger deal. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
